Methods to treat one or all of the defined etiologies of female sexual dysfunction
First Claim
Patent Images
1. A compound for the topical manual application directly to the female clitoris containing Vardenafil, L-arginine and;
- Menthol or any cooling agent listed below, having a concentration of less than 0.5% and greater than 0.01%;
a) wherein said cooling agent includes menthol b) wherein said cooling agent includes peppermint oil;
c) wherein said cooling agent includes cornmint oil. d) wherein said cooling agent includes Eucalypus oil. e) wherein said cooling agent includes Citronella oil. f) wherein said cooling agent includes Camphor oil. g) wherein said cooling agent includes Cinnamon oil. h) Wherein said cooling agent essentially comprises Menthol i) wherein said cooling agent essentially comprises peppermint oil. j) wherein said cooling agent essentially comprises cornmiint oil. k) wherein said cooling agent essentially comprises Eucalyptus'"'"' oil. l) wherein said cooling agent essentially comprises Citronella oil. m) wherein said cooling agent essentially comprises Camphor oil. n) wherein said cooling agent essentially comprises Cinnamon oil. o) wherein said cooling agent includes a menthol analog or derivative with cooling properties;
Menthol Analogs and Derivatives (+)-neo-Menthol Menthone (+)-iso-Menthone Menthyl acetate Menthyl isovalerate (−
)-Menthyl lactate para-menth-1-en-3ol Piperitone (−
)-Menthol ethylene glycol carbonate (−
)-Menthol 1-and 2-propylene glycol carbonate (−
)-Menthone 1,2-glycerol ketal (+)-Menthone 1,2-glycerol ketal mono-Menthyl succinate
1 Assignment
0 Petitions
Accused Products
Abstract
The U.S. Food and Drug Administration defines the four separate components of Female Sexual Dysfunction (FSD) to be decreased sexual desire, decreased sexual arousal, dyspareunia (pain with intercourse), and persistent difficulty in achieving or inability to achieve orgasm (anorgasmia). To establish a diagnosis of FSD, these components must be associated with personal distress, as determined by the affected woman. A topical combination of menthol/L-arginine and the specific 5-PDE inhibitor vardenafil can be used to treat any of the defined components, or a combination of two or more of the defined components of FSD, as a safe, first-line therapy for FSD.
-
Citations
18 Claims
-
1. A compound for the topical manual application directly to the female clitoris containing Vardenafil, L-arginine and;
Menthol or any cooling agent listed below, having a concentration of less than 0.5% and greater than 0.01%;
a) wherein said cooling agent includes menthol b) wherein said cooling agent includes peppermint oil;
c) wherein said cooling agent includes cornmint oil. d) wherein said cooling agent includes Eucalypus oil. e) wherein said cooling agent includes Citronella oil. f) wherein said cooling agent includes Camphor oil. g) wherein said cooling agent includes Cinnamon oil. h) Wherein said cooling agent essentially comprises Menthol i) wherein said cooling agent essentially comprises peppermint oil. j) wherein said cooling agent essentially comprises cornmiint oil. k) wherein said cooling agent essentially comprises Eucalyptus'"'"' oil. l) wherein said cooling agent essentially comprises Citronella oil. m) wherein said cooling agent essentially comprises Camphor oil. n) wherein said cooling agent essentially comprises Cinnamon oil. o) wherein said cooling agent includes a menthol analog or derivative with cooling properties;
Menthol Analogs and Derivatives (+)-neo-Menthol Menthone (+)-iso-Menthone Menthyl acetate Menthyl isovalerate (−
)-Menthyl lactatepara-menth-1-en-3ol Piperitone (−
)-Menthol ethylene glycol carbonate(−
)-Menthol 1-and 2-propylene glycol carbonate(−
)-Menthone 1,2-glycerol ketal(+)-Menthone 1,2-glycerol ketal mono-Menthyl succinate - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current Assignee40 J's LLC (Callitas Health, Inc.)
-
Original Assignee40 J's LLC (Callitas Health, Inc.)
-
InventorsThompson, Ronald J., Thompson, Justin R., Thompson, James M.
-
Application NumberUS11/176,546Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/171CPC Class CodesA61H 19/34 For clitoral stimulationA61H 19/50 Devices for use during sexu...A61K 2300/00 Mixtures or combinations of...A61K 31/045 Hydroxy compounds, e.g. alc...A61K 31/198 Alpha-amino acids, e.g. ala...A61K 31/53 having six-membered rings w...A61K 31/557 Eicosanoids, e.g. leukotrie...A61K 31/56 Compounds containing cyclop...A61K 36/534 Mentha (mint)A61K 36/54 Lauraceae (Laurel family), ...A61K 36/61 Myrtaceae (Myrtle family), ...A61K 36/899 Poaceae or Gramineae (Grass...A61K 9/0034 Urogenital system, e.g. vag...
